Atacicept — Drug Intelligence | 4 EU Trials

Filter these 4 trials by condition, phase, country and more.

4 Registered trials

2 Recruiting

2 Completed trials

1 Sponsors

13 Countries

Phase II/III

Phase II

Phase II/III: 1 Phase II: 3

Indications tested

4 total

Atacicept in Multiple Glomerular Diseases Recruiting

2024-518465-10-00 Phase II 6 countries Vera Therapeutics Inc.
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept Recruiting

2024-516380-81-00 Phase II 6 countries Vera Therapeutics Inc.
A Study Evaluating Monthly (Every 4 Weeks) Dosing of Atacicept in Patients with IgAN Ended

2025-521519-37-00 Phase II 2 countries Vera Therapeutics Inc.
Atacicept in Subjects with IgA Nephropathy (ORIGIN and ORIGIN 3) Ended

2023-503772-24-00 Phase II/III 13 countries Vera Therapeutics Inc.

Showing 1–4 of 4 trials